Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Virtual presentation scheduled for Thursday, February 26th at 12:40 PM ET Access the webcast hereCarlsbad, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) ...
Medscape

Diagnostic Value of Terminal Ileum Intubation During Colonoscopy

We reviewed all colonoscopic procedures performed in the endoscopy center of Ajou University Hospital, which is a 1000-bed teaching hospital, between 1 January 2005 and 31 December 2005. Six ...
Medscape

Ileal Resection Tied to Higher CRC Risk in Crohn's Disease

Patients with Crohn's disease who undergo terminal ileum resection have a significantly higher risk of developing colorectal cancer (CRC) and colorectal polyps than those who do not undergo resection.
Nature

CT enterography improves detection if Crohn's disease skips the distal ileum

Crohn's disease could be missed by ileocolonoscopy if the condition skips the distal ileum or is limited to the mesentary or intramural portion of the bowel wall, but CT enterography can aid detection ...
Seeking Alpha

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and ...

Carlsbad, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing ...
KXAN

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the ...

At Week 54, patients receiving infliximab SC achieved significantly greater efficacy outcomes across all endpoints compared with placebo, regardless of disease location. Rates of clinical remission ...